In June 2019, The Stem Cell Network launched a new national research funding competition comprised of four translational research programs in stem cell and regenerative medicine. The first funding competition is for projects and clinical trials up to 25 months in length (January 1, 2020 – January 31, 2022). SCN anticipates that a second competition will be launched in early 2020. Together, $11 million will be made available through these peer-reviewed funding competitions to support Canadian stem cell research. Note: Funding is dependent on the completion of SCN’s 2019-22 contribution agreement with the Government of Canada. (See Research Funding Programs below).
NEW: Disruptive Research Program LOI
On July 11, SCN launched the Disruptive Research Program (DRP) with a specific (LOI) Letters of Intent process that is only applicable to this program. The DRP will support national, multidisciplinary research projects that bring forward high-impact ideas and approaches to enable innovative and transformative research that will seed subsequent translation activity.
LOI submissions welcome – July 11, 2019
LOI submission deadline – August 23, 2019 (11:59 PM Pacific Time)
LOI responses and invitations to submit full application issued – September 17, 2019
Full application deadline – November 8, 2019
Anticipated funding start date – January 1, 2020
All LOI submissions must be emailed on or before the deadline to: Rebecca Cadwalader at firstname.lastname@example.org. A confirmation email will be sent within 48 hours of SCN receiving the submitted LOI package. If a confirmation email is NOT received from SCN within 48 hours of submission it is the responsibility of the lead applicant to contact SCN and ensure that the application package has been received.
Research Funding Programs – Now Closed
Call for Proposals, applications welcome – June 13, 2019
Call for Proposals closes, application deadline – August 8, 2019 (11:59 PM Pacific Time)
Award notifications – December 2019
All applications must be emailed on or before the deadline to: Rebecca Cadwalader at email@example.com. A confirmation email will be sent within 48 hours of SCN receiving the submitted application package. If a confirmation email is NOT received from SCN within 48 hours of submission it is the responsibility of the lead applicant to contact SCN and ensure that the application package has been received.
Accelerating Clinical Translation Program
The Accelerating Clinical Translation program supports multi-disciplinary research projects that are moving toward the clinic. This program will also support translational research activities (including ELSI questions) associated with an upcoming or ongoing clinical trial.
Fueling Biotechnology Partnerships Program
The Fueling Biotechnology Partnerships program supports academic partnerships with emerging Canadian regenerative medicine biotech companies who are working to drive an innovative stem cell-based technology or therapy into the clinic or market.
Advancing Clinical Trials Program
The Advancing Clinical Trials program supports early stage clinical trial projects with high translational potential. This program focuses on novel cellular or stem cell-related therapeutic approaches to tissue repair and regeneration for specific diseases. The clinical trials within this program will be led by academics working in leading Canadian research institutions and will bring forward innovative therapies or technologies of potential value to the Canadian health care system.
Translation and Society Program
The Translation & Society program supports ethical, legal and social implications (ELSI) projects that that focus on impediments to progress in the translation of innovative stem cell research.